About Kan Innovations
Kan Innovations is a company based in Mumbai (India) founded in 2018. It operates as a B2B. The company has 6 employees. Kan Innovations offers products and services including Vital. PT OHM Series and AFORA. Kan Innovations operates in a competitive market with competitors including NuvoAir, MedTel Healthcare, Neurosynaptic, WuXi Diagnostics and Coagulo, among others.
- Headquarter Mumbai, India
- Employees 6
- SectorsHealthcare
- Website kaninnovations.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Kan Innovations Private Limited
- Date of Incorporation 09 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹2.44 Cr
FY 2024 · +13% YoY
- Net Loss-₹1.22 Cr
FY 2024 · -50% margin
- EBITDA-₹74.7 Lakh
FY 2024 · -31% margin
- Employee Count6
Associated legal entities of Kan Innovations
Kan Innovations operates through Kan Innovations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kan Innovations Private Limited CIN U93090MH2019PTC323862 | Active | 09 Apr 2019 | Mumbai, Maharashtra | ₹2.4 Cr | 6 | 2 | View details |
Products & Services of Kan Innovations
Kan Innovations offers a comprehensive portfolio of products and services, including Vital. PT OHM Series and AFORA.
AI tool for gait and posture analysis in rehabilitation therapy.
Device for detecting neuropathic and vascular issues in diabetes care.
Board of directors of Kan Innovations Private Limited (Kan Innovations)
Kan Innovations Private Limited is the primary company behind Kan Innovations. The board of Kan Innovations Private Limited currently have 2 directors; the longest-serving is Riday Pradeep Nakhate, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Riday Pradeep Nakhate DIN 08416693 | Director | 09 Apr 2019 | 7 yrs 6 mo | Kan Innovations Private Limited |
| Bharat Kalyanji Gala DIN 08416694 | Director | 09 Apr 2019 | 7 yrs 6 mo | Kan Innovations Private Limited |
Financials of Kan Innovations
Figures of Kan Innovations Private Limited, the primary company behind Kan Innovations, for FY 2024. Revenue was ₹2.44 Cr (+13% year on year). Net loss was -₹1.22 Cr (-50% margin). EBITDA was -₹74.7 Lakh (-31% margin). Revenue has grown at a compounded annual rate of +107% over three years.
- ₹2.44 CrRevenue · FY 2024 · +13% YoY
- -₹1.22 CrNet loss · -50% margin
- -₹74.7 LakhEBITDA · -31% margin
- ₹10 LakhPaid-up capital
- 6Employees (provident fund records)
- +107%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Kan Innovations Private Limited are on its company page.
Detailed financial statements for Kan Innovations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Kan Innovations
Kan Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, MedTel Healthcare, Neurosynaptic, WuXi Diagnostics and Coagulo, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nuvoair.com | 2015 | Stockholm, Sweden | $28.1M | – | Clinical decision support tools for respiratory diseases are provided. | |
| medtel.io | 2016 | Bengaluru, India | $996,158 | 23 | Remote patient monitoring software is developed for healthcare providers. | |
| neurosynaptic.com | 2002 | Bengaluru, India | $1.61M | 29 | ICT-based products and solutions are developed for healthcare. | |
| wuxidiagnostics.com | 2018 | Rochester, United States | $200M | – | Diagnostic solutions for disease identification are offered to healthcare providers. | |
| coagulomed.com | 2018 | Newton, United States | $6.5M | – | Precision-medicine platform for blood coagulation disease diagnosis is offered. | |
| immuneiq.com | 2008 | Minneapolis, United States | $54.99M | – | A point-of-care platform for diagnosing immune diseases is provided. | |
| zio-health.com | 2015 | London, United Kingdom | – | 5 | Molecular-level home analysis and monitoring for personalized healthcare is offered. | |
| surfixdx.com | 2021 | Wageningen, Netherlands | $19.51M | – | Provider of photonics diagnostic platform |
Detailed competitors of Kan Innovations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kan Innovations
Complete news archive for Kan Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Kan Innovations
10 companies that operate in the same segment as Kan Innovations (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kan Innovations
Kan Innovations was founded in 2018.
Kan Innovations is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Kan Innovations has 6 employees.
The primary company behind Kan Innovations, Kan Innovations Private Limited, reported revenue of ₹2.44 Cr for FY 2024, up 13% year on year.
Kan Innovations, a Mumbai-based company founded in 2019, focuses on AI-driven solutions to enhance human biomechanics in healthcare. They offer products for precise gait and posture analysis in physiotherapy, as well as tools for detecting diabetic foot issues. Their services include data-driven rehabilitation, gamified therapy, and early prevention strategies, empowering clinics, experts, and universities through research-backed innovations and distribution networks.
Kan Innovations's top competitors include MedTel Healthcare, Neurosynaptic and WuXi Diagnostics.
Kan Innovations offers Vital. PT OHM Series and AFORA.
Kan Innovations operates through Kan Innovations Private Limited.
The legal entities of Kan Innovations currently have 2 directors, including Riday Pradeep Nakhate, Bharat Kalyanji Gala.